Abstract B003: Lesion distribution and prognosis of renal cell carcinoma bone metastasis: A novel evaluation model based on random survival forests

Abstract Introduction and Objective: The prognostic significance of bone metastasis (BM) distribution in renal cell carcinoma (RCC) is unclear, as commonly used tools such as the Memorial Sloan Kettering Cancer Center (MSKCC)/Motzer score don’t account for the spatial bone lesion patterns. This study aimed to quantify the association between bone metastasis distribution and prognosis in RCC-BM patients and to build a predictive model based on the random survival forest (RSF) algorithm. Materials and Methods: At first BM diagnosis, 122 patients were stratified by MSKCC/Motzer risk score and classified into locoregional (thoracic/lumbar vertebrae limited, 21.3%), stochastic (random bone lesions without visceral involvement, 56.6%) and extensive (bone plus visceral metastases, 22.1%) groups based on bone lesion distribution. Spinal, pelvic, upper extremity and lower extremity involvement occurred in 39.3%, 35.2%, 18.0% and 16.4% of cases. Univariate analysis, logistic regression, and Kaplan-Meier survival analyses assessed associations between bone lesion distribution and clinical risk. A RSF model was developed for survival prediction. The performance was compared to Cox regression using time-dependent area under the curve (AUC) analyses with repeated random train-validation splits. Results: Locoregional spread, spinal involvement (odds ratio/OR 3.30, 95% CI 1.20–9.09, p<0.05) and advanced age (OR 1.04, 95% CI 1.00–1.08, p<0.05) predicted higher MSKCC/Motzer risk stratification. Pelvic metastasis yielded shorter median overall survival (32 vs 49 months; p<0.05). The RSF model was trained (70%) and validated (30%) with spatial lesion involvement (pelvic, spinal and upper extremity involvement), MSKCC/Motzer score and age. In single split validation, 1- and 3-year AUCs were 0.90 and 0.87. Consistent performance was observed across 100 repeated splits, with median AUCs of 0.89, 0.86 and 0.89 for 1-, 3- and 5-year survival. A cutoff of 15.03 distinguished high- and low-risk groups (p<0.05). RSF outperformed over Cox regression (median AUC 0.89 vs 0.59). Conclusion: This study identifies the distribution patterns as prognosis indicators. Locoregional and spinal metastasis predict higher risks in MSKCC/Motzer system. Incorporating these factors into RSF model with MSKCC/Motzer score improves risk stratification in RCC-BM patients and supports more precise care. Citation Format: Zixiong Huang, Xiaopeng Zhang, Shijun Liu, Srinivas Nallandhighal, Tao Xu, Simpa Salami. Lesion distribution and prognosis of renal cell carcinoma bone metastasis: A novel evaluation model based on random survival forests [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Innovations in Kidney Cancer Research: From Molecular Insights to Therapeutic Breakthroughs; 2026 Mar 13-16; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2026;86(5_Suppl_2):Abstract nr B003.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-03-13
DOI
https://doi.org/10.1158/1538-7445.kidney26-b003
Primary Topic
Management of metastatic bone disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract B003: Lesion distribution and prognosis of renal cell carcinoma bone metastasis: A novel evaluation model based on random survival forests

Shijun Liu, Srinivas Nallandhighal, Zixiong Huang, Xiaopeng Zhang et al.
Cancer Research
Management of metastatic bone disease
article

Abstract B003: Lesion distribution and prognosis of renal cell carcinoma bone metastasis: A novel evaluation model based on random survival forests

Shijun Liu, Srinivas Nallandhighal, Zixiong Huang, Xiaopeng Zhang, Tao Xu, Simpa Salami
article en

Abstract

Abstract Introduction and Objective: The prognostic significance of bone metastasis (BM) distribution in renal cell carcinoma (RCC) is unclear, as commonly used tools such as the Memorial Sloan Kettering Cancer Center (MSKCC)/Motzer score don’t account for the spatial bone lesion patterns. This study aimed to quantify the association between bone metastasis distribution and prognosis in RCC-BM patients and to build a predictive model based on the random survival forest (RSF) algorithm. Materials and Methods: At first BM diagnosis, 122 patients were stratified by MSKCC/Motzer risk score and classified into locoregional (thoracic/lumbar vertebrae limited, 21.3%), stochastic (random bone lesions without visceral involvement, 56.6%) and extensive (bone plus visceral metastases, 22.1%) groups based on bone lesion distribution. Spinal, pelvic, upper extremity and lower extremity involvement occurred in 39.3%, 35.2%, 18.0% and 16.4% of cases. Univariate analysis, logistic regression, and Kaplan-Meier survival analyses assessed associations between bone lesion distribution and clinical risk. A RSF model was developed for survival prediction. The performance was compared to Cox regression using time-dependent area under the curve (AUC) analyses with repeated random train-validation splits. Results: Locoregional spread, spinal involvement (odds ratio/OR 3.30, 95% CI 1.20–9.09, p<0.05) and advanced age (OR 1.04, 95% CI 1.00–1.08, p<0.05) predicted higher MSKCC/Motzer risk stratification. Pelvic metastasis yielded shorter median overall survival (32 vs 49 months; p<0.05). The RSF model was trained (70%) and validated (30%) with spatial lesion involvement (pelvic, spinal and upper extremity involvement), MSKCC/Motzer score and age. In single split validation, 1- and 3-year AUCs were 0.90 and 0.87. Consistent performance was observed across 100 repeated splits, with median AUCs of 0.89, 0.86 and 0.89 for 1-, 3- and 5-year survival. A cutoff of 15.03 distinguished high- and low-risk groups (p<0.05). RSF outperformed over Cox regression (median AUC 0.89 vs 0.59). Conclusion: This study identifies the distribution patterns as prognosis indicators. Locoregional and spinal metastasis predict higher risks in MSKCC/Motzer system. Incorporating these factors into RSF model with MSKCC/Motzer score improves risk stratification in RCC-BM patients and supports more precise care. Citation Format: Zixiong Huang, Xiaopeng Zhang, Shijun Liu, Srinivas Nallandhighal, Tao Xu, Simpa Salami. Lesion distribution and prognosis of renal cell carcinoma bone metastasis: A novel evaluation model based on random survival forests [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Innovations in Kidney Cancer Research: From Molecular Insights to Therapeutic Breakthroughs; 2026 Mar 13-16; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2026;86(5_Suppl_2):Abstract nr B003.

Cancer ResearchVol. 86(5_Supplement_2)
King University (US), Peking University (CN), University of Michigan (US), Michigan Medicine (US), Peking University People's Hospital (CN)
Life in Land
Openalex Percentile: Top 23%
Management of metastatic bone disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.